AmRest Holdings Valuation
Is EAT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EAT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EAT (PLN21.2) is trading above our estimate of fair value (PLN1.35)
Significantly Below Fair Value: EAT is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EAT?
Key metric: As EAT is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is EAT's PS Ratio? | |
|---|---|
| PS Ratio | 0.4x |
| Sales | €2.52b |
| Market Cap | €1.06b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1x |
| Enterprise Value/EBITDA | 9.5x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does EAT's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.9x | ||
STH STS Holding | 6.6x | n/a | zł3.9b |
MEX Mex Polska | 0.3x | n/a | zł33.0m |
RBW Rainbow Tours | 0.5x | 10.2% | zł1.8b |
SFS Sfinks Polska | 0.2x | n/a | zł16.1m |
EAT AmRest Holdings | 0.4x | 5.3% | zł4.6b |
Price-To-Sales vs Peers: EAT is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (1.9x).
Price to Sales Ratio vs Industry
How does EAT's PS Ratio compare vs other companies in the European Hospitality Industry?
| 24 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 24 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: EAT is good value based on its Price-To-Sales Ratio (0.4x) compared to the European Hospitality industry average (1x).
Price to Sales Ratio vs Fair Ratio
What is EAT's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.4x |
| Fair PS Ratio | 0.4x |
Price-To-Sales vs Fair Ratio: EAT is good value based on its Price-To-Sales Ratio (0.4x) compared to the estimated Fair Price-To-Sales Ratio (0.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | zł21.20 | zł24.72 +16.6% | 14.1% | zł29.40 | zł20.00 | n/a | 5 |
| Nov ’25 | zł21.00 | zł24.72 +17.7% | 14.1% | zł29.40 | zł20.00 | n/a | 5 |
| Oct ’25 | zł23.10 | zł24.84 +7.5% | 14.5% | zł29.40 | zł20.00 | n/a | 5 |
| Sep ’25 | zł23.00 | zł24.84 +8.0% | 14.5% | zł29.40 | zł20.00 | n/a | 5 |
| Aug ’25 | zł24.10 | zł25.24 +4.7% | 14.7% | zł29.40 | zł20.00 | n/a | 5 |
| Jul ’25 | zł24.60 | zł25.96 +5.5% | 18.0% | zł33.00 | zł20.00 | n/a | 5 |
| Jun ’25 | zł25.65 | zł25.96 +1.2% | 18.0% | zł33.00 | zł20.00 | n/a | 5 |
| May ’25 | zł26.35 | zł26.53 +0.7% | 15.2% | zł31.00 | zł20.00 | n/a | 4 |
| Apr ’25 | zł24.40 | zł28.70 +17.6% | 5.9% | zł31.00 | zł27.00 | n/a | 3 |
| Mar ’25 | zł24.95 | zł28.70 +15.0% | 5.9% | zł31.00 | zł27.00 | n/a | 3 |
| Feb ’25 | zł26.60 | zł28.70 +7.9% | 5.9% | zł31.00 | zł27.00 | n/a | 3 |
| Jan ’25 | zł26.60 | zł28.70 +7.9% | 5.9% | zł31.00 | zł27.00 | n/a | 3 |
| Dec ’24 | zł25.10 | zł28.70 +14.3% | 5.9% | zł31.00 | zł27.00 | n/a | 3 |
| Nov ’24 | zł26.70 | zł31.53 +18.1% | 17.9% | zł39.50 | zł27.00 | zł21.00 | 3 |
| Oct ’24 | zł25.20 | zł29.65 +17.7% | 19.8% | zł39.50 | zł24.00 | zł23.10 | 4 |
| Sep ’24 | zł28.85 | zł27.33 -5.3% | 8.2% | zł30.20 | zł24.00 | zł23.00 | 4 |
| Aug ’24 | zł28.75 | zł27.33 -5.0% | 8.2% | zł30.20 | zł24.00 | zł24.10 | 4 |
| Jul ’24 | zł23.00 | zł31.76 +38.1% | 42.3% | zł57.50 | zł19.00 | zł24.60 | 5 |
| Jun ’24 | zł22.95 | zł25.33 +10.3% | 16.9% | zł30.20 | zł19.00 | zł25.65 | 4 |
| May ’24 | zł18.76 | zł23.45 +25.0% | 13.9% | zł28.10 | zł19.00 | zł26.35 | 4 |
| Apr ’24 | zł18.84 | zł25.75 +36.7% | 9.5% | zł28.20 | zł22.70 | zł24.40 | 4 |
| Mar ’24 | zł19.76 | zł27.90 +41.2% | 14.8% | zł32.80 | zł22.70 | zł24.95 | 3 |
| Feb ’24 | zł20.50 | zł27.90 +36.1% | 14.8% | zł32.80 | zł22.70 | zł26.60 | 3 |
| Jan ’24 | zł19.56 | zł26.57 +35.8% | 16.0% | zł32.80 | zł22.57 | zł26.60 | 4 |
| Dec ’23 | zł20.00 | zł26.57 +32.8% | 16.0% | zł32.80 | zł22.57 | zł25.10 | 4 |
| Nov ’23 | zł18.40 | zł26.15 +42.1% | 16.0% | zł32.80 | zł21.00 | zł26.70 | 5 |
Analyst Forecast: Target price is less than 20% higher than the current share price.